Nara Organics Recalls Infant Formula
Analysis based on 44 articles · First reported Jun 13, 2026 · Last updated Jun 15, 2026
The recall of Nara Organics infant formula due to botulism concerns will negatively impact the company's stock price and reputation. Retailers like Oracle Corporation may also experience a slight negative impact due to their association with the recalled product, though the overall market impact is limited as Nara Organics represents a small fraction of the infant formula market.
Nara Organics has voluntarily recalled all lots of its Whole Milk Organic Powdered Infant Formula sold nationwide in Target stores and online after three infants in United States — California, United States — Pennsylvania, and Washington were diagnosed with infant botulism. The infants, aged 2 to 5 months, became ill between April and May after consuming the formula and were successfully treated with Baby BIG. While no Nara formula has tested positive for Clostridium botulinum bacteria to date, the company initiated the recall out of an abundance of caution. The United States — Food and Drug Administration and the United States — Centers for Disease Control and Prevention are investigating the outbreak and have advised parents to immediately stop using the recalled formula. The recall is not expected to cause a nationwide formula shortage as Nara Organics accounts for less than 1% of the U.S. infant formula market.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard